Media: Roche's Genentech licenses rights to experimental eye cell therapy from Lineage - WSJ
20/12/2021 10:05
-- Source link: https://on.wsj.com/30HhOcA
-- Note: Reuters has not verified this story and does not
vouch for its accuracy
((Bengaluru newsroom, globalnewsmonitoring@thomsonreuters.com))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million